SterRx, LLC recalls dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh
Recalled January 5, 2022 · FDA recall D-0315-2022 · SterRx
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
8946 bags
Sold at
U.S.A. Nationwide
Description
Lack of Assurance of Sterility
Product
dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.
Manufacturer(s)
SterRx, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →